T ropospheric ozone (O 3 ) is an oxidant that damages agriculture, ecosystems, and materials. Ozone also adversely affects human health and has been associated in epidemiologic studies with daily premature mortality (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Surface O 3 concentrations have historically increased in both polluted and remote regions and now frequently exceed regulatory standards (11) (12) (13) (14) . Global background surface O 3 concentrations have roughly doubled since preindustrial times (15) , primarily because of increases in anthropogenic emissions of nitrogen oxides (NO x ) and methane (CH 4 ) (16) , and are projected to continue to increase (17, 18) .
Tropospheric O 3 is formed from photochemical reactions involving NO x and volatile organic compounds (VOCs). Although nonmethane VOCs are the dominant anthropogenic VOCs contributing to O 3 formation in polluted regions, CH 4 is the primary anthropogenic VOC in the global troposphere (19) . Because CH 4 reacts slowly (lifetime of 8-9 yr), it affects global background concentrations of O 3 . Because this background underlies the O 3 produced on urban and regional scales, CH 4 mitigation reduces O 3 concentrations by roughly the same amount in polluted regions as in rural regions (19, 20) .
Methane and O 3 are also greenhouse gases, which rank behind only carbon dioxide (CO 2 ) in anthropogenic radiative forcing of climate (21) . Consequently, abatement of CH 4 emissions both reduces surface O 3 concentrations everywhere and slows greenhouse warming (19, 20) . Methane abatement has been considered a low-cost means of addressing climate change (22, 23) , particularly to influence the short-term rate of climate change. However, CH 4 abatement has not been considered for air quality management, mainly because O 3 pollution has traditionally been considered a local and regional problem, and the local benefits of local CH 4 reductions are small.
Here we examine the global reduction in O 3 and consequent decrease in premature human mortalities resulting from CH 4 emission controls. We first estimate the global decrease in surface O 3 concentration due to CH 4 mitigation, using the MOZART-2 global three-dimensional tropospheric chemistrytransport model (24, 25) . This spatial distribution of O 3 is then overlaid on projections of population, and avoided premature mortalities are estimated by using daily O 3 -mortality relationships from epidemiologic studies (6) (7) (8) (9) . Results are presented as the number of avoided premature mortalities due to the CH 4 reduction, the marginal cost-effectiveness per avoided mortality (using the marginal cost of CH 4 mitigation), and the monetized benefit per tonne of CH 4 reduced [using a value of a statistical life (VSL)].
Response of Global Surface Ozone to Methane Mitigation
Methods. We consider a CH 4 emission reduction of 65 Mt⅐yr
Ϫ1
(1 Mt ϭ 10 9 kg) (Ϸ20% of current global anthropogenic emissions), which is assumed to be immediate in 2010 and sustained relative to the Intergovernmental Panel on Climate Change Special Report on Emissions Scenarios (SRES) A2 scenario (26) until 2030. A compilation of global CH 4 abatement options in five industrial sectors (27) suggests that 65 Mt⅐yr Ϫ1 can be reduced by 2010 at a net cost savings, using identified abatement options.
The MOZART-2 simulations use uniform global mixing ratios of CH 4 , and spatially and temporally distributed emissions of other O 3 precursors, as other studies have done (19, 28) . We conduct four simulations with MOZART-2, as shown in Table  1 Table 2 ). This sensitivity is in agreement with other models (18, 19, 28, 33) , and these results together suggest that global surface O 3 responds fairly linearly to changes in CH 4 (33) . Decreases in O 3 due to CH 4 reductions are widespread globally ( Fig. 1) , with the largest O 3 decreases occurring over the Middle East, North Africa, and Europe, because of greater down-welling from the free troposphere and greater availability of NO x . This spatial pattern is similar to previous results (19, 20) , suggesting that the pattern is independent of the extent of methane abatement. Methane controls initiated in 2010 will yield Ϸ81% of this steady-state O 3 change by 2030, assuming exponential decay with a CH 4 perturbation lifetime of Ϸ12 yr (28 4 . This insensitivity presumably reflects the fact that there is little change in hydroxyl radical (OH) concentrations, because of similar emission ratios of NO x to (CO ϩ VOCs) in 2000 and 2030 (16) . Therefore, although the A2 scenario includes larger growth in emissions of O 3 precursors than other SRES scenarios, and larger than the ''Current Legislation'' scenario of Dentener et al. (18) , this high growth does not strongly affect the O 3 -CH 4 sensitivity.
Indirect Effects of Methane Reductions on Particulate Matter (PM).
Methane reductions also indirectly affect PM concentrations through complex oxidant chemistry. MOZART-2 (25) results suggest that CH 4 reductions cause a global net decrease in inorganic PM, because of decreases in hydrogen peroxide that in turn reduce sulfate production. Inorganic PM concentrations also increase at some locations, where the increased gas-phase oxidation (due to increased OH concentrations) dominates the change in sulfate production. Although the global average decrease is only Ϸ0.5% of the inorganic PM (sulfate, nitrate, and associated ammonium), the decrease is concentrated in populated regions. Confidence in the change in PM is lower than for O 3 because of competing influences on inorganic PM, and because we have neglected changes in organic PM.
Global Mortality Benefits of Reduced Ozone
Methods. Ozone has been associated in epidemiologic studies with adverse health effects including hospital admissions and 
directly use a large data set, and therefore their results are not subject to publication bias, which can bias meta-analyses high. The ␤ estimated by Bell et al. (6) with a single-day lag is much smaller than the ␤ estimated in three recent meta-analyses (7-9). However, the ␤ of Bell et al. (6) with the distributed lag method, used in this study, is much more comparable with the meta-analyses (7-9), which are 22-36% higher. We consider the sensitivity of our results to the uncertainties reported by Bell et al. (6) and the meta-analyses (7) (8) (9) (5, 6) . Rather than imposing seasonally varying relationships, we assume a low-concentration threshold of 25 ppbv, approximately the preindustrial mixing ratio (13, 15) , below which we neglect any effect of O 3 on mortality. We apply this threshold on each day, through all seasons, and consider the sensitivity of our results to the threshold used.
We apply ␤ to the total nonaccident baseline mortality rates, using data for 14 world regions (38) . Baseline mortality rates are applied uniformly within each region, and are assumed to be constant into the future. The spatial distribution of population is modeled consistently with the SRES A2 scenario, growing to 9.17 billion in 2030 (26) .
Avoided premature mortalities are estimated daily in each model grid square, based on the maximum daily 8-h O 3 mixing ratio in the A2 base and CH 4 Table 3 and Fig. 2 show that reducing CH 4 emissions by 65 Mt⅐yr Ϫ1 in 2010 would prevent Ϸ30,000 all-cause premature mortalities in the year 2030 (Ϸ0.04% of the total projected mortalities), with Ϸ370,000 avoided premature mortalities accumulated between 2010 and 2030. These avoided mortalities are distributed globally, with the majority in highly populated regions (Table 3 and Fig. 3 ). Mortality benefits per million people in 2030 are highest in Africa, which has high baseline mortality rates, followed by Europe and the eastern Mediterranean. Table 4 shows a large sensitivity to ␤ over the range of uncertainties in Bell et al. (6) and three meta-analyses (7-9). The avoided mortalities also vary with the sensitivity of O 3 to CH 4 but are rather insensitive to the low-concentration threshold over the range considered. This insensitivity occurs because regions with low O 3 typically also have low population and small changes in O 3 due to CH 4 ; O 3 is below 25 ppbv on Ϸ12% of populated grid square-days in 2030, but the number of avoided mortalities decreases by only 2% relative to the no-threshold case.
The mortality benefits of O 3 decreases are most uncertain in developing nations, where fewer epidemiologic studies exist and the general causes of death differ substantially from those in industrialized nations. As a more conservative estimate, we consider the avoided cardiovascular and respiratory (CR) mortalities, because these may be more closely linked to O 3 . We apply the ␤ for CR mortalities from Bell et al. (6) , which is higher than for total mortalities but not significantly different, to baseline CR mortality rates. In Table 3 , Ϸ17,000 premature CR mortalities can be avoided globally in 2030 by the CH 4 emission reduction, with the greatest per capita benefits in Europe, where relatively more people die of CR causes. Although our estimates of avoided CR mortalities may be more robust in developing nations than total mortalities, they likely miss important decreases in other causes of mortality. Henceforth, we use an uncertainty range from the estimated avoided CR mortalities (Ϸ17,000 in 2030) to the highest number in Table 4 (Ϸ56,000).
Effects of Changes in PM on Mortality. By using the changes in inorganic PM in the previous section and a chronic PM-mortality relationship (34) , the avoided 2030 mortalities are estimated to be less than, but comparable with, the O 3 benefit (see the supporting information). The effects of CH 4 reductions on both inorganic and organic PM should be further investigated, including changes in PM precursor emissions from energy sources possibly displaced because of increased CH 4 availability.
Policy Analysis of Ozone Control by Means of Methane Mitigation
A compilation of global CH 4 abatement measures from five industrial sectors (27) shows that Ϸ41 Mt⅐yr Ϫ1 can be reduced at a negative marginal cost (net cost-savings, through natural gas recovery), which can be justified regardless of health benefits.
The 65 Mt⅐yr
Ϫ1 reduction has a marginal cost of Ϸ$100 per tonne of CH 4 (2000 U.S. dollars), whereas the net cost of this reduction is negative. We combine this marginal cost with the all-cause avoided premature mortalities, which we convert to a constant annualized benefit between 2010 and 2030 at a 5% yr Ϫ1 discount rate (see the supporting information), yielding $420,000 per avoided mortality ($230,000-$760,000) as the marginal costeffectiveness of reducing 65 Mt⅐yr Ϫ1 . The 65 Mt⅐yr Ϫ1 reduction would be justified, in cost-benefit terms, for any globally averaged VSL Ͼ$420,000.
If we use $1 million as a reasonable globally averaged VSL (39), the monetized benefit of reducing CH 4 emissions is $240 per tonne of CH 4 ($140 -$450), or $12 per tonne of CO 2 equivalent ($7-$22), which exceeds the marginal cost of the 65 Mt⅐yr Ϫ1 reduction (Ϸ$100 per tonne of CH 4 ). This estimate neglects increases in the VSL as incomes grow, and only considers 20 yr of benefits, whereas the O 3 reductions will continue growing beyond 2030 as population also grows. The monetized benefit scales proportionally with the assumed globally averaged VSL.
Because CH 4 reductions have recently traded in international markets at $10-$20 per tonne of CO 2 equivalent, these results suggest that current climate-motivated CH 4 emission reductions can roughly be justified by their benefits to air quality and health, irrespective of other benefits of CH 4 and O 3 reductions. Furthermore, although the ancillary benefits of CO 2 mitigation for air quality and health have received attention (40), the ancillary Using base values gives 30,200 avoided premature mortalities. *Percent excess mortality per ppbv change in 8-h O3 mixing ratio. The range spans the 95% confidence intervals of four studies (6 -9) . † Range applied as scaling factors to the change in daily 8-h O3 in each grid square.
benefits of CH 4 mitigation have not. Our estimate for CH 4 of $12 per tonne of CO 2 equivalent is comparable with the range estimated previously for CO 2 of $0.5-$140 per tonne of CO 2 (41) . Unlike the ancillary benefits of CO 2 mitigation, however, the ancillary benefits of CH 4 mitigation do not depend on the location or means of CH 4 abatement, because the health benefits of CH 4 mitigation result from reactions involving the CH 4 itself, and CH 4 emissions affect O 3 globally regardless of emission location.
The compilation of CH 4 abatement measures used in this study (27) considers five industrial sectors (coal, oil, and natural gas operations, landfills, and wastewater treatment) for which methane abatement opportunities are well understood. Because this compilation neglects abatement opportunities in the large agricultural sector, it may underestimate the availability of low-cost CH 4 options, which would suggest that CH 4 mitigation is more cost-effective than estimated here. On the other hand, a separate compilation by the U.S. Environmental Protection Agency (42) (43) (44) suggests that less CH 4 can be reduced at low cost (see the supporting information and ref. 20) .
Methane mitigation also benefits climate, because it reduces the radiative forcing of both CH 4 (45), with a net effect that could be positive or negative depending on location (46) .
Methane is also an important source of global energy, and capturing half of the 65 Mt⅐yr Ϫ1 for energy use would provide Ϸ2% of current global natural gas production. The reductions in O 3 concentrations would also result in benefits to human health (morbidity) and agriculture (47), which we previously estimated to be smaller than the monetized benefits of avoided mortalities estimated here (20) . Methane mitigation may further benefit air quality and climate by removing other pollutants (e.g., VOCs) through the same actions that reduce CH 4 emissions, and by increasing the availability of natural gas, which may reduce emissions of CO 2 and air pollutants from the combustion of other fossil fuels. In addition, because the reductions in O 3 are widespread globally, CH 4 mitigation may increase the net primary productivity of plants, causing increased uptake of CO 2 (48) . Finally, methane mitigation may affect stratospheric O 3 , but the direction of that inf luence is not certain (49) .
The effects of CH 4 mitigation on surface O 3 concentrations are widespread globally, and are delayed. These characteristics differ from other means of controlling O 3 , as well as most actions to manage air quality, which abate local and regional pollution over hours to weeks. Because of its global impacts, with small local benefits, CH 4 mitigation for air quality purposes (as for climate) will best be implemented at national and international levels. Furthermore, the potential for reducing O 3 through CH 4 mitigation is limited to a few parts per billion by volume. Methane mitigation is therefore most appropriate for international and long-term (decadal) O 3 management, where CH 4 mitigation for background O 3 is complementary to local and regional O 3 management through reductions in emissions of NO x and nonmethane VOCs (20) .
Important uncertainties in this study lie in the relationship between O 3 and mortality, and between CH 4 emissions and global surface O 3 concentrations. Because CH 4 affects O 3 globally, this research highlights the need to improve understanding of O 3 mortality in developing nations, and of the relationship between O 3 and mortality at low concentration, including consideration of possible thresholds. Future research should also investigate the effects of CH 4 mitigation on PM concentrations, and its implications for air quality, public health, and climate. Finally, future research should further examine opportunities to abate CH 4 emissions, emphasizing the large agricultural sector.
Conclusions
As background O 3 concentrations increase, meeting national O 3 standards increasingly becomes an international problem (50) (51) (52) . Methane mitigation reduces surface O 3 everywhere, offering a unique opportunity to improve air quality globally. We estimate that reducing Ϸ20% of current global anthropogenic CH 4 emissions, which can be achieved at a net cost-savings by using identified technologies, will reduce O 3 mixing ratios globally by Ϸ1 ppbv and prevent Ϸ30,000 premature mortalities globally in 2030 and Ϸ370,000 mortalities between 2010 and 2030. If these mortalities are valued at $1 million each, the monetized benefit is Ϸ$240 per tonne of CH 4 , or Ϸ$12 per tonne of CO 2 equivalent. These benefits exceed the marginal costs of the 20% anthropogenic CH 4 reduction (Ϸ$100 per tonne of CH 4 ) and demonstrate that CH 4 mitigation has ancillary benefits to air quality and human health that are comparable with those previously estimated for CO 2 . Methane mitigation benefits air quality, public health, agriculture, climate, and energy, and should increasingly be considered a cost-effective component of international long-term O 3 management.
